A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

计划入组 225 人 · 首次发布于 2024 年 4 月 16 日

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

计划入组 185 人 · 首次发布于 2019 年 7 月 17 日

Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer

计划入组 1,163 人 · 首次发布于 2024 年 4 月 2 日

Chimeric Endocrine Receptor T-cell therapy (Wistar Institute)

Endocrine Target(Agonist)(septerna)

endocrine disease therapeutics, Therakind

Endocrine Research Society

Canada

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

Real-World Study Affirms Palbociclib's Efficacy in Chinese HR+/HER2- Metastatic Breast Cancer Patients

EUROPA Trial: Radiotherapy Preserves Quality of Life Better Than Endocrine Therapy in Older Breast Cancer Patients

Breast Cancer Index Test Could Enable Personalized Endocrine Therapy Duration in HR+ Breast Cancer